Genetic association of sirtuin genes and Parkinson's disease

Journal of Neurology

Volumn 260, Issue 9, 2013, Pages 2237-2241

  Jesús, Silvia ^a   Gómez Garre, Pilar ^a,b   Carrillo, Fátima ^a   Cáceres Redondo, María T ^a   Huertas Fernández, Ismael ^a   Bernal Bernal, Inmaculada ^a   Bonilla Toribio, Marta ^a   Vargas González, Laura ^a   Carballo, Manuel ^a   Mir, Pablo ^a,b  

^a Instituto de Biomedicina de Sevilla   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Parkinson's disease; Polymorphism; Sirtuins

Indexed keywords

MICRORNA; SIRTUIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE BINDING SITE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SIRTUINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84884354416     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6970-7     Document Type: Article

References (24)

1. Puschman A (2013) Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord 19:407-415
2. Chartier-Harlin MC, Dachsel JC, Vilarino-Guell C et al (2011) Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet 89:398-406
3. Deng H, Gao K, Jankovic J (2013) The VPS35 gene and Parkinson's disease. Mov Disord 28(5):569-575
4. Dali-Youcet N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J (2007) Sirtuins: the "magnificent seven", function, metabolism and longevity. Ann Med 39:335-345
5. Mine JC, Denu JM (2008) The Sirtuin family: therapeutic targets to treat disease of aging. Curr Opin Chem Biol 12:11-17
6. Kim D, Nguyen MD, Dobbin MM et al (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26:3169-3179
7. Jiang M, Wang J, Fu J et al (2011) Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med 18:153-158
8. Donmez G, Arun A, Chung CY, McLean PJ, Lindquist S, Guarente L (2012) SIRT1 protects against a-synuclein aggregation by activating molecular chaperones. J Neurosci 32:124-132
9. Wareski P, Vaarmann A, Choubey V et al (2009) PGC-1a and PGC-1b regulate mitochondrial density in neurons. J Biol Chem 284:21379-21385
10. Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against cocconi2908 by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122
11. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159:993-1002
12. Outeiro TF, Kontopoulos E, Altmann SM et al (2007) Sirtuin 2 inhibitors rescue a-synuclein-mediated toxicity in models of Parkinson's disease. Science 317:516-519
13. Liu L, Arun A, Peritore C, Donmez G (2012) Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahidropyridine (MPTP)-induced nigroestriatal damage via deacetylating forehead box O3a (Foxo3a) and activating Bim protein. J Biol Chem 287:32307-32311
14. Hirschey MD, Shimazu T, Goetzman E et al (2010) SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation. Nature 582:543-548
15. Kanfi Y, Shalman R, Peshtia V, Pilosofa SN, Gozlana YM, Pearsonb KJ, Lerrera B, Moazedc D, Marined J-C, Cabob R, Cohena H (2008) Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett 582:543-548
16. Raghavan A, Shah ZA (2011) Sirtuins in neurodegenerative diseases: a biological-chemical perspective. Neurodegener Dis 9:1-10
17. Brown K, Xie S, Qiu X et al (2013) SIRT3 reverses aging-associated degeneration. Cell Rep 3:319-327
18. Kanfi Y, Naiman S, Amir G et al (2012) Sirtuin SIRT6 regulates lifespan in male mice. Nature 483:218-221
19. Glorioso C, Sunghee O, Douillard GG, Sibille E (2011) Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism. Neurobiol Dis 41:279-290
20. Barber M, Michishita-Kioi E, Xi Y et al (2012) SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487:114-118
21. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
22. Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575
23. Zhang A, Wang H, Qin X, Pang S, Yan B (2012) Genetic analysis of SIRT1 gene promoter in sporadic Parkinson's disease. Biochem Biophys Res Commun 422:693-696
24. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100:10794-10799